Answers are grounded in this paper and cite their sources.
Demonstrates ECM-driven pseudo-resistance in COVID-19 and cancer, suggesting new treatment pathways.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rejinold et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: